APGE logo

APGE
Apogee Therapeutics

439
Mkt Cap
$5.99B
Volume
397,260.00
52W High
$88.35
52W Low
$31.21
PE Ratio
-20.47
APGE Fundamentals
Price
$86.27
Prev Close
$86.52
Open
$86.53
50D MA
$72.56
Beta
0.00
Avg. Volume
1.31M
EPS (Annual)
-$4.22
P/B
6.53
Rev/Employee
$0.00
$3,859.60
Loading...
Loading...
News
all
press releases
Insider Selling: Apogee Therapeutics (NASDAQ:APGE) CEO Sells 20,000 Shares of Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of the firm's stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $82.58, for a total transaction of $1,651,600.00. Following the completion of the...
MarketBeat·15h ago
News Placeholder
More News
News Placeholder
Aberdeen Group plc Lowers Stake in Apogee Therapeutics Inc. $APGE
Aberdeen Group plc lessened its stake in Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 34.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional...
MarketBeat·1d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High - Still a Buy?
Apogee Therapeutics (NASDAQ:APGE) Reaches New 12-Month High - Should You Buy...
MarketBeat·2d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Insider Sells $466,620.00 in Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 5,500 shares of the firm's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average...
MarketBeat·7d ago
News Placeholder
Insider Selling: Apogee Therapeutics (NASDAQ:APGE) Insider Sells 5,500 Shares of Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 5,500 shares of the firm's stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $84.84, for a total transaction of $466,620.00. Following the transaction, the insider directly...
MarketBeat·8d ago
News Placeholder
Banque Pictet & Cie SA Invests $3.16 Million in Apogee Therapeutics Inc. $APGE
Banque Pictet & Cie SA purchased a new position in Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the...
MarketBeat·8d ago
News Placeholder
SG Americas Securities LLC Sells 60,964 Shares of Apogee Therapeutics Inc. $APGE
SG Americas Securities LLC cut its stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 45.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 73,262 shares of the company's stock after selling 60,96...
MarketBeat·9d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Sets New 52-Week High - Here's What Happened
Apogee Therapeutics (NASDAQ:APGE) Sets New 1-Year High - Here's What Happened...
MarketBeat·10d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Price Target Raised to $110.00 at Mizuho
Mizuho upped their price target on shares of Apogee Therapeutics from $105.00 to $110.00 and gave the company an "outperform" rating in a research report on Monday...
MarketBeat·12d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Reaches New 52-Week High - Here's Why
Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High - Here's What Happened...
MarketBeat·16d ago
<
1
2
...
>

Latest APGE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.